Scientists and clinicians at TRI are working towards improved diagnosis and treatment of various cancers including breast, prostate, head and neck, and skin cancers.

In 2018, an estimated 140,000 new cases of cancer were diagnosed, and just under 50,000 people died from the disease (AIHW, 2018). In Australia, the most commonly diagnosed cancers are currently breast cancer, followed by prostate cancer, colorectal cancer and melanoma.(AIHW, 2018

Researchers at TRI are working closely with clinicians to identify novel ways to detect, diagnose, monitor and treat various types of cancers. These projects include specialist cancer groups across QUT's Institute of Health and Biomedical Innovation, Mater Research, The University of Queensland.

Image: Cancer tumour spheroid with fluorescent labelling according to cell phenotype. Crystal Tonnessen (June 2015).

Key Researchers
Andrew Perkins
Nicholas Andrew Saunders
Colleen Nelson
Geoffrey Faulkner
Ingrid Winkler
Jean-Pierre Levesque
John Hooper
Judith Clements
Kristen Radford
Maher Gandhi
Show More ...
Click a program below to learn more
Blood Cancer
Breast Cancer
Cervical Cancer
Head and Neck Cancer
Kidney Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Interview with Prof John Hooper about pancreatic cancer research
QUT biomedical scientists affiliated with TRI have developed a simple saliva test, which has detected early throat cancer in a person who had no symptoms and no clinical signs of cancer. In what is...Read more
Australian scientists are ready to trial a new ‘precision-medicine’ agent designed to deliver imaging agents and anti-cancer drugs to ovarian and pancreatic cancers in patients with...Read more
A drug currently in clinical trials has the potential to improve the survival rate of Australians diagnosed with acute myeloid leukaemia, following the outcomes of preclinical research by Mater...Read more
University of Queensland (UQ) researchers based at TRI are unlocking the secrets of melanoma cells to identify potential new drug targets and personalised treatment regimens for patients with the...Read more
Scientists from Mater Research – The University of Queensland, have discovered they can overcome chemotherapy resistance in an ovarian cancer subtype by using low doses of a drug which slows...Read more
Mater researchers based at TRI have partnered with QUT’s Institute of Health and Biomedical Innovation (IHBI) to establish a unique breast cancer biobank to better support Queensland...Read more
Australians with melanoma detected before they turn 40 are more likely to have the cancer on non-sun damaged parts of the body compared to people diagnosed when older. University of Queensland...Read more
The Translational Research Institute (TRI) has awarded a research grant to fund a Phase I clinical trial for an innovative new treatment for head and neck cancer associated with Human Papillomavirus...Read more
Cancer cells gain and lose so-called ‘chromosome arms’ during tumour growth, with researchers finding these changes can help predict drug response and patient survival rates as well as...Read more
An important collaboration between researchers from the Mater Hospital, the Translational Research Institute (TRI) and the Griffith Institute for Drug Discovery (GRIDD) has led to a significant...Read more